N/A
N=12
Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes
Type 2 Diabetes
Bottom Line
View on ClinicalTrials.gov: NCT02180646 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcome: Primary: Plasma Glucose Level Post-meal (AUC [0-4]) — 28426; 33911 min*pg/ml
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- High protein breakfast (Other); High carb breakfast (Other)
- Age
- Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Missouri-Columbia
- Primary completion
- Apr 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Plasma Glucose Level Post-meal (AUC [0-4]) |
28426; 33911 | — |
| SECONDARY Post-meal Level of Glucose-dependent Insulinotropic Peptide (GIP) (AUC) |
15156; 14620 | — |
Summary
This study examined the effect of a high protein or high carbohydrate breakfast on the glucose and insulin response following the breakfast meal, as well as the subsequent response following the lunch meal.
Eligibility Criteria
Inclusion Criteria
- 21-55 y of age
- body mass index (BMI) between 30-40 kg/m2
- weight stable for the prior 6 months
- non-smokers
- minimal alcohol consumption (< 2 drinks per day)
- type 2 diabetic (diagnosed ≥ 2 y)
- a fasting glucose level above 120 mg/dL
- HbA1c between 6.5-9.0%
Exclusion Criteria
- insulin
- β-blockers
- GLP-1 agonists (e.g. exenatide)
- dipeptidyl peptidase (DPP) inhibitors
- weight loss
- using weight-loss medications
- pregnant or lactating
Data sourced from ClinicalTrials.gov (NCT02180646). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.